Press Releases Novonesis A/S

Equities

Real-time Estimate Cboe Europe Other stock markets 03:42:47 2024-04-30 EDT			5-day change	1st Jan Change
391.6 ^DKK	+0.50%		+0.21%	+4.90%

04-08	Novozymes A/S Proposes Dividend for the Last Four Months Ended December 31, 2023	CI
03-26	China to speed up 'new productive forces', vice president says	RE

Novonesis A/S : Invitation to the annual shareholders' meeting	04-08	PU
Invitation to the annual shareholders’ meeting	04-08	GL
Share-based legacy RSU program granted	04-08	GL
2024 outlook and pro forma financials	03-21	GL
2024 outlook and pro forma financials	03-21	AQ
Novonesis will host a conference call regarding 2024 outlook and 2023 pro forma financials on March 21	03-18	GL
Novonesis A/S : Resolutions from the Extraordinary Shareholders' Meeting 2024	03-04	PU
Resolutions from the Extraordinary Shareholders’ Meeting 2024	03-04	GL
Invitation to an extraordinary shareholders’ meeting of Novozymes A/S	02-09	GL
The Novozymes Report 2023	02-08	GL
Trading by management and close relations of management	02-02	GL
Settlement of the combination of Novozymes and Chr. Hansen Holding successfully completed	02-02	GL
Legacy Novozymes delivers solid last full-year results	02-01	GL
Results update for 2023 – unaudited	02-01	GL
Legacy Novozymes delivers solid last full-year results	02-01	AQ
Results update for 2023 – unaudited	02-01	AQ
Trading by management and close relations of management	01-29	GL
Major shareholder announcement	01-29	GL
The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner	01-29	GL
Completion of the combination between Novozymes and Chr. Hansen	01-29	GL

No results for this search

NOVOZYMES : Q4 23: destocking noise offsets recovery in other key segments

February 08, 2024 at 09:18 am